Colony Forming Unit (CFU) and Endotoxin (LAL) Testing

Microbial testing services are required for water samples sourced from the Renal Dialysis Unit to measure colony forming units and endotoxin levels using the limulus amebocyte lysate methodology, with all procedures strictly aligned to AAMI and FDA regulatory standards. The work must ensure the safety and purity of dialysis water by accurately detecting microbial contamination that could compromise patient health, adhering to validated laboratory protocols and quality control measures. The contract is classified as a subcontract with a NAICS code of 541380 and is managed by the Department of Veterans Affairs through the 260-NETWORK Contract Office 20, with performance to be conducted at a location in Seattle, Washington, 98108. Proposals must be submitted by the deadline of July 11, 2026, following the solicitation posted on June 17, 2026. All testing outcomes must be documented and reported in a manner that supports regulatory compliance and audit readiness, maintaining the highest standards of accuracy and traceability in results.